The 9 references in paper I. Yavelov S., И. ЯВЕЛОВ С. (2015) “СОВРЕМЕННОЕ ЛЕЧЕНИЕ ВЕНОЗНЫХ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ АНТИКОАГУЛЯНТАМИ: ВОЗМОЖНОСТИ АПИКСАБАНА // CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN” / spz:neicon:aterotromboz:y:2015:i:2:p:32-38

1
Konstantinides S, Torbicki A, Agnelli G et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Endorsed by the European Respiratory Society (ERS). Eur Heart J, 2014. 35: 3033–3069.
(check this in PDF content)
2
Prandoni P, Lensing AW, Cogo A et al. .The long-term clinical course of acute deep venous thrombosis. Ann Ann Intern Med, 1996. Jul 1. 125(1): 1–7.
(check this in PDF content)
3
Prandoni P, Villalta S, Bagatella P et al. The clinical course of deep-vein thrombosis. Prospective longterm follow-up of 528 symptomatic patients. Haematologica, 1997. 82: 423–428.
(check this in PDF content)
4
Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet,2003. 362: 523–526.
(check this in PDF content)
5
Eichinger S, Weltermann A, Minar E et al. Symptomatic Pulmonary Embolism and the Risk of Recurrent Venous Thromboembolism. Arch Intern Med,2004. 164: 92–96.
(check this in PDF content)
6
Couturaud F, Sanchez O, Pernod G et al; for the PADISPE Investigators. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary EmbolismThe PADIS-PE Randomized Clinical Trial. JAMA, 2015. 314: 31–40.
(check this in PDF content)
7
Agnelli G, Buller HR, Cohen A et al, for the AMPLIFY Investigators. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. N Engl J Med, 2013. 369: 799–808.
(check this in PDF content)
8
Agnelli G, Buller HR, Cohen A et al, for the AMPLIFYEXT Investigators Apixaban for Extended Treatment of Venous Thromboembolism. N Engl J Med,2013. 368: 699–708.
(check this in PDF content)
9
Schulman S, Kearon C, Kakkar AK et al.; the RESONATE Trials Investigators. Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism. N Engl J Med, 2013. 368: 709–718.
(check this in PDF content)